Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Makumi

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The International Journal of Neuroscience|January 20, 2011
Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's diseaseRobert A Hauser, Heinz Reichmann, Mark Lew, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The International Journal of Neuroscience|January 20, 2011
Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's diseaseRobert A Hauser, Heinz Reichmann, Mark Lew, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Pageof 1